Physician
Westfields Hospital, INC.
Westfields Hospital, INC. was paid $8.53M by Medicaid between Jan 2018 and Dec 2024, across 176 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 25% of everything it billed.
33Billing provider infoWESTFIELDS HOSPITAL, INC.
NEW RICHMOND, WI 54017
NEW RICHMOND, WI 54017
33aNPI1881640183assigned 05/26/2006
33bProvider typeFamily Medicine Physician
28Total paid$8.53M
24GClaims243,539
24DCodes billed176
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Wisconsin
Rank by total paid#6 of 359
Median peer was paid$4K
This provider vs. median2,194×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,963 | $1.02M | |
| 2019 | 33,778 | $1.09M | |
| 2020 | 28,305 | $1.02M | |
| 2021 | 38,932 | $1.27M | |
| 2022 | 39,157 | $1.23M | |
| 2023 | 39,666 | $1.50M | |
| 2024incomplete | 31,738 | $1.40M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 44,149 | 30,928 | $2.16M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 21,983 | 14,095 | $1.28M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 8,679 | 6,888 | $1.05M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.3% | 6,006 | 4,447 | $624K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.3% | 3,540 | 2,617 | $371K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.6% | 816 | 673 | $304K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.9% | 1,564 | 1,352 | $245K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.7% | 2,835 | 2,198 | $229K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.4% | 3,005 | 2,629 | $202K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.0% | 934 | 828 | $168K |
| 96127 | 1.9% | 7,039 | 5,414 | $165K | |
| 92551 | 1.6% | 1,810 | 1,682 | $132K |
164 more codes
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.2% | 2,618 | $100K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.1% | 821 | $96K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.1% | 965 | $92K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,112 | $68K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,526 | $65K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 664 | $63K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,730 | $51K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 207 | $45K |
| 80053 | Comprehensive metabolic panel | <1% | 4,652 | $41K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 398 | $39K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,672 | $37K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,185 | $36K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 4,052 | $35K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,408 | $35K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 529 | $35K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,706 | $34K |
| 85027 | <1% | 5,920 | $32K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 171 | $31K |
| 81025 | <1% | 1,522 | $26K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,103 | $24K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 503 | $24K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 569 | $23K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 351 | $23K |
| 90686 | <1% | 1,449 | $23K | |
| 81001 | <1% | 4,918 | $22K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 327 | $21K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 838 | $20K |
| 90670 | <1% | 214 | $20K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,265 | $18K |
| 80061 | Lipid panel | <1% | 1,699 | $17K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,005 | $17K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 219 | $17K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 533 | $16K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,174 | $15K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,354 | $13K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 90 | $12K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 154 | $11K |
| 84484 | <1% | 1,895 | $10K | |
| 85610 | <1% | 1,989 | $10K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 247 | $10K |
| 73630 | <1% | 675 | $10K | |
| 90651 | <1% | 113 | $10K | |
| 83605 | <1% | 1,569 | $10K | |
| 91320 | <1% | 183 | $9K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 334 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,250 | $8K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 107 | $7K |
| 82248 | <1% | 2,762 | $7K | |
| 87088 | <1% | 502 | $6K | |
| 83735 | <1% | 1,689 | $6K | |
| 99173 | <1% | 844 | $6K | |
| 0012A | <1% | 258 | $6K | |
| 83690 | <1% | 1,367 | $6K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 347 | $6K |
| 86140 | <1% | 1,606 | $6K | |
| 0011A | <1% | 265 | $6K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 146 | $5K |
| 87077 | <1% | 918 | $5K | |
| 36592 | <1% | 931 | $5K | |
| 87186 | <1% | 556 | $5K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 263 | $5K |
| 0001A | <1% | 217 | $5K | |
| 90715 | <1% | 220 | $5K | |
| 0002A | <1% | 166 | $5K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,083 | $5K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 89 | $4K |
| 90734 | <1% | 76 | $4K | |
| 90480 | <1% | 228 | $4K | |
| 99188 | <1% | 359 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 16,297 | $4K |
| 84145 | <1% | 355 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 98 | $4K |
| 80076 | <1% | 517 | $4K | |
| 90661 | <1% | 173 | $4K | |
| 85018 | <1% | 570 | $3K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 26 | $3K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 66 | $3K |
| 90674 | <1% | 180 | $3K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 182 | $3K |
| 90633 | <1% | 119 | $3K | |
| 87210 | <1% | 258 | $3K | |
| 82728 | <1% | 207 | $2K | |
| 73562 | <1% | 111 | $2K | |
| 87634 | <1% | 38 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 82 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 72 | $2K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 36 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 401 | $2K |
| 87081 | <1% | 191 | $2K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 49 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,308 | $2K |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 95 | $1K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 19 | $1K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 43 | $1K |
| 0072A | <1% | 48 | $1K | |
| 97162 | <1% | 47 | $1K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,933 | $1K |
| 86803 | <1% | 107 | $1K | |
| 96161 | <1% | 77 | $1K | |
| 0124A | <1% | 101 | $1K | |
| 82607 | <1% | 131 | $1K | |
| 36416 | <1% | 832 | $1K | |
| 82565 | <1% | 235 | $1K | |
| 0004A | <1% | 44 | $1K | |
| 87070 | <1% | 124 | $1K | |
| 90723 | <1% | 68 | $1K | |
| 99205 | Prolong outpt/office vis | <1% | 17 | $1K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 33 | $918.61 |
| 82947 | <1% | 272 | $893.00 | |
| 84466 | <1% | 97 | $847.64 | |
| 90647 | <1% | 24 | $840.37 | |
| 0071A | <1% | 42 | $800.64 | |
| 90680 | <1% | 13 | $795.60 | |
| 0064A | <1% | 34 | $774.98 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 26 | $741.20 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 309 | $651.92 |
| 82077 | <1% | 60 | $511.34 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,049 | $492.27 |
| 82570 | <1% | 156 | $488.98 | |
| 83540 | <1% | 99 | $443.54 | |
| 82043 | <1% | 52 | $404.79 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,053 | $395.95 |
| 73030 | <1% | 29 | $379.97 | |
| 90677 | <1% | 33 | $308.72 | |
| 84460 | <1% | 97 | $248.72 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 704 | $234.53 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 783 | $201.93 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 141 | $196.15 |
| 80306 | <1% | 13 | $194.81 | |
| 86618 | <1% | 16 | $187.14 | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 29 | $182.62 |
| 81003 | <1% | 103 | $174.42 | |
| 82962 | <1% | 47 | $173.20 | |
| 83880 | <1% | 28 | $162.28 | |
| 90473 | <1% | 16 | $162.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 14 | $156.06 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 344 | $148.74 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,029 | $141.24 |
| 86780 | <1% | 15 | $133.56 | |
| 87205 | <1% | 56 | $126.94 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 815 | $107.76 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 637 | $76.75 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 45 | $70.06 |
| A9270 | Non-covered item or service | <1% | 3,436 | $66.66 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 258 | $65.14 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 31 | $62.88 |
| 90474 | <1% | 41 | $43.95 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 425 | $37.39 |
| 90662 | <1% | 48 | $32.32 | |
| 85652 | <1% | 14 | $25.11 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 672 | $22.87 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 236 | $19.32 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 94 | $10.04 |
| G0008 | Administration of influenza virus vaccine | <1% | 446 | $1.27 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 1,125 | $0.25 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 486 | $0.10 |
| 91301 | 0% | 13 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 189 | $0.00 |
| 99417 | Prolong home eval add 15m | 0% | 32 | $0.00 |
| 0352U | 0% | 37 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 42 | $0.00 |
| 90694 | 0% | 69 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 26 | $0.00 |
| 90653 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOHNSON, DOUGLAS (CFO)
| Provider | Location | Paid |
|---|---|---|
| Hudson Hospital, INC. | Hudson, WI | $3.59M |
| Lakeview Memorial Hospital Association INC | Stillwater, MN | $3.11M |
| Sports & Wellness Physical Therapy, INC. | San Luis Obispo, CA | $655K |
| Douglas W Johnson, MD, INC | Honolulu, HI | $367K |
| Lakeview Memorial Hospital Association INC. | Stillwater, MN | $365K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.